Mylan Pharmaceuticals Inc. has voluntarily recalled 215,685 bottles of various Valsartan-containing medications, including Amlodipine and Valsartan (generic Exforge), Valsartan (generic Diovan), and Valsartan and Hydrochlorothiazide (generic Diovan HCT). These medications, used to treat high blood pressure and heart failure, were found to contain an impurity called N-nitrosodiethylamine (NDEA). This impurity was detected in the active ingredient manufactured in India and is classified as a probable human carcinogen. To date, no injuries or adverse events have been reported specifically related to this recall.
The medications contain N-nitrosodiethylamine (NDEA), a substance that occurs naturally in certain foods and drinking water but is classified as a probable human carcinogen. Long-term exposure to levels above safety limits may increase the risk of cancer.
Drug replacement and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.